REQUEST A DEMO
Total
USD $0.00
Search more companies

Intervencionismo Cardiaco S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Intervencionismo Cardiaco S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Intervencionismo Cardiaco S.A.S. is based in Ecuador, with the head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on March 17, 2024. 2 (2024) employees currently work for Intervencionismo Cardiaco S.A.S.. In its most recent financial highlights, the company reported a net sales revenue increase of 549.06% in 2025. Its’ total assets recorded a growth of 674.72%. The net profit margin of Intervencionismo Cardiaco S.A.S. decreased by 18.3% in 2025.

Headquarters
Av. de la Prensa, N58-154
Quito; Pichincha;

Contact Details: Purchase the Intervencionismo Cardiaco S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Intervencionismo Cardiaco S.A.S. report to view the information.
Registered Capital:
Purchase the Intervencionismo Cardiaco S.A.S. report to view the information.
Financial Auditors:
Purchase the Intervencionismo Cardiaco S.A.S. report to view the information.
Incorporation Date:
March 17, 2024
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Intervencionismo Cardiaco S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
549.06%
Total Operating Revenue
549.06%
Operating Profit
347.12%
EBITDA
347.12%
Net Profit/Loss for the Period
337.77%
Total Assets
674.72%
Total Equity
431.99%
Operating Profit Margin
-17.57%
Net Profit Margin
-18.3%
Return on Equity (ROE)
-17.48%
Quick Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?